ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

156 Episodio

1. ACCEL Lite: Pre-Eclampsia: Maternal Red Flag of Risk

   Pubblicato: 14/7/2022
2. ACCEL Lite: Black Maternal Health: A Call to Action and Implications for Prevention

   Pubblicato: 13/7/2022
3. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Return to Play

   Pubblicato: 5/7/2022
4. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Post-acute Sequelae

   Pubblicato: 28/6/2022
5. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Myocarditis

   Pubblicato: 21/6/2022
6. ACCEL Lite: Inflamed! Populations at Risk for Inflammation Associated CVD

   Pubblicato: 14/6/2022
7. ACCEL Lite: Significant Updates from the 2021 ACC Coronary Artery Revascularization Guidelines

   Pubblicato: 7/6/2022
8. ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR

   Pubblicato: 24/5/2022
9. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Pubblicato: 17/5/2022
10. ACCEL Lite: ACC.22 Late Breaker: CHAP RCT -- Antihypertensive Therapy For Mild Chronic Hypertension Improves Pregnancy Outcomes

    Pubblicato: 10/5/2022
11. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

    Pubblicato: 3/5/2022
12. ACCEL Lite: Late Breaker: Mavacamten as an Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Pubblicato: 26/4/2022
13. ACCEL Lite: Late Breaker: SODIUM-HF: Dietary Intervention Under 100 Mmol In Heart Failure

    Pubblicato: 19/4/2022
14. ACCEL Lite: Late Breaker: METEORIC-HF: The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic HFrEF

    Pubblicato: 12/4/2022
15. ACCEL Lite: Late Breaker: DIAMOND trial: Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications For HFrEF

    Pubblicato: 5/4/2022
16. ACCEL Lite: Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice

    Pubblicato: 22/3/2022
17. ACCEL Lite: When Is Genetic Testing Helpful?

    Pubblicato: 15/3/2022
18. ACCEL Lite: Special Considerations in Screening of Masters Athletes with CAD

    Pubblicato: 8/3/2022
19. ACCEL Lite: Helping Patients Improve Lifestyle Behavior in the Digital Era

    Pubblicato: 1/3/2022
20. ACCEL Lite: Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis--Focus on AL

    Pubblicato: 22/2/2022